MTOR and cancer: The PI3K/AKT and mTOR signaling pathways play a key role in cell proliferation, survival, and metabolism and are two of the most commonly dysregulated oncogenic pathways in cancers, including renal cell carcinoma, breast cancer, mantle cell lymphoma, adult soft tissue cancer, and bone sarcomas [6].